Medtronic Seeks Dismissal Of InFuse Securities Case
Medtronic Inc. has asked a judge to dismiss a putative securities class action related to the off-label use of its InFuse spinal graft product, arguing that the mere disclosure that the...To view the full article, register now.
Already a subscriber? Click here to view full article